Golden has been acquired by ComplyAdvantage.Read about it here ⟶

‌

US Patent 10377750 5-methyl-1,3,4-oxadiazol-2-yl compounds

Patent 10377750 was granted and assigned to Eli Lilly and Company on August, 2019 by the United States Patent and Trademark Office.

Overview Structured Data Issues Contributors Activity

Is a

Patent

Patent attributes

Patent Applicant

Eli Lilly

Current Assignee

Eli Lilly

Patent Jurisdiction

United States Patent and Trademark Office

Patent Number

103777500

Patent Inventor Names

Nicolas Jacques Francois Dreyfus0

Peter James Lindsay-Scott0

Richard Edmund Rathmell0

Date of Patent

August 13, 2019

Patent Application Number

159832690

Date Filed

May 18, 2018

Patent Citations

‌

US Patent 10081625 5-methyl-1,2,4-oxadiazol-3-yl compounds

Patent Citations Received

‌

US Patent 11999726 5-methyl-4-fluoro-thiazol-2-yl compounds

‌

US Patent 11839654 Combination therapy

Patent Primary Examiner

‌

Rita J Desai

Patent abstract

The present invention provides a compound of Formula I:

Timeline

No Timeline data yet.

Further Resources

Title

Author

Link

Type

Date

No Further Resources data yet.

References

Find more entities like US Patent 10377750 5-methyl-1,3,4-oxadiazol-2-yl compounds

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.

Open Query Tool

Access by API